Beximco Synthetics’ earnings plunge further, pharma sees rise

The earnings of Beximco Synthetics Ltd has gone down by a further 25% while Beximco Pharmaceuticals Ltd saw a rise of 24% in its earnings.

According to the statement published on the Dhaka Stock Exchange (DSE) website, Beximco Synthetics’ earnings per share (EPS) was negative Tk0.85 for Q1 (July-September) of 2020 against negative Tk0.68 for the same period last year.

The company’s net operating cash flow per share (NOCFPS) was Tk0.0001 for Q1 of 2020 against Tk0.28 for the same period last year.

Meanwhile, the net asset value (NAV) per share was negative Tk2.25 on September 30 and negative Tk1.40 on June 30 this year.

In a separate statement in DSE, Beximco Pharmaceuticals Ltd reported a consolidated EPS of Tk2.65 for Q1 of 2020 against Tk2.13 for the same period last year.

Its consolidated NOCFPS was Tk3 for Q1 of 2020 against Tk4.59 for the same period last year.

NAV per share of Beximco Pharma was Tk82.78 on September 30, 2020, against Tk75.09 on September 30 last year.